We highlight the absence of high-level evidence from dose-ranging studies regarding the use of oral ivermectin in susceptible parasitic diseases. We provide published data supporting the use of a higher dosage regimen of ivermectin in malaria and difficult-to-treat head lice, and announce an ongoing randomized clinical trial in severe scabies.
All Keywords
【저자키워드】 malaria, Head lice, scabies, Oral ivermectin, High doses,
【저자키워드】 malaria, Head lice, scabies, Oral ivermectin, High doses,